tirzepatide mace Risk of major adverse cardiovascular events and stroke associated with treatment with GLP-1 or the dual GIP/GLP-1 receptor agonist for type 2 diabetes: A systematic review and meta-analysis Tirzepatide: A Systematic Update

US$ 19.99

★★★★★ 4.7 (24 reviews)

US$ 24.25

★★★★★ 4.8 (17 reviews)

US$ 21.39

★★★★★ 4.8 (12 reviews)

US$ 22.38

★★★★★ 4.1 (18 reviews)

US$ 29.58

★★★★★ 4.2 (7 reviews)

US$ 25.21

★★★★★ 4.7 (27 reviews)

US$ 29.22

★★★★★ 4.3 (22 reviews)

US$ 28.26

★★★★★ 5.0 (21 reviews)

US$ 21.11

★★★★★ 4.4 (23 reviews)

US$ 22.19

★★★★★ 4.2 (21 reviews)

US$ 21.87

★★★★★ 4.7 (21 reviews)

US$ 20.60

★★★★★ 4.7 (21 reviews)

US$ 26.33

★★★★★ 4.7 (26 reviews)

US$ 29.38

★★★★★ 4.0 (21 reviews)

US$ 29.30

★★★★★ 5.0 (18 reviews)

US$ 23.43

★★★★★ 4.6 (30 reviews)

US$ 28.20

★★★★★ 4.5 (7 reviews)

US$ 26.72

★★★★★ 4.7 (9 reviews)

US$ 24.41

★★★★★ 4.8 (16 reviews)

US$ 23.66

★★★★★ 5.0 (29 reviews)